Herein, we present a case of cardiomyopathy in AS in whom ejection fraction and New York Heart Association (NYHA)functional class improved and disease activity decreased after cardiac rehabilitation program.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Ankylosing spondylitis (AS) is a chronic inflammatory disease which is characterized by the primary involvement of axial spine andsacroiliac joints and also extraarticular involvements including ophthalmological, cardiac, pulmonary, or neurological effects.
📊
Key Findings & Data:Cardiacinvolvement in patients with AS has been reported to be 2 to 10%.
💡
Conclusion & Impact:Herein, we present a case of cardiomyopathy in AS in whom ejection fraction and New York Heart Association (NYHA)functional class improved and disease activity decreased after cardiac rehabilitation program.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
Ankylosing spondylitis (AS) is a chronic inflammatory disease which is characterized by the primary involvement of axial spine andsacroiliac joints and also extraarticular involvements including ophthalmological, cardiac, pulmonary, or neurological effects. Cardiacinvolvement in patients with AS has been reported to be 2 to 10%. Ventricular dysfunctions have been previously reported in patients with AS.However, there is only one case report describing primary cardiomyopathy due to AS and management with better control of inflammationand medications. Herein, we present a case of cardiomyopathy in AS in whom ejection fraction and New York Heart Association (NYHA)functional class improved and disease activity decreased after cardiac rehabilitation program.
🔖
Cite This Article
GİRAY, E., YAĞCI, İ. (2019). Cardiac rehabilitation in a patient with ankylosing spondylitis: A single-program, double-effect. Turkish journal of physical medicine and rehabilitation, Cilt: 65 - Sayı: 2, 194–197. https://ajindex.com/articles/375158
Momeni M, Taylor N, Tehrani M. Cardiopulmonary manifestations of ankylosing spondylitis. Int J Rheumatol 2011;2011:728471
Heeneman S, Daemen MJ. Cardiovascular risks in spondyloarthritides. Curr Opin Rheumatol 2007;19:358-62
Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos- Vargas R, Collantes-Estevez E, et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2011;70:896-904
Lui NL, Thumboo J, Inman R. Cardiomyopathy in ankylosing spondylitis. Arthritis Care Res (Hoboken) 2011;63:564-9
Gabriel SE. Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis? Arthritis Rheum 2008;58:637-40
Kwon HJ, Coté TR, Cuffe MS, Kramer JM, Braun MM. Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med 2003;138:807-11
Graham DC, Smythe HA. The carditis and aortitis of ankylosing spondylitis. Bull Rheum Dis 1958;9:171-4
Gould BA, Turner J, Keeling DH, Hickling P, Marshall AJ. Myocardial dysfunction in ankylosing spondylitis. Ann Rheum Dis 1992;51:227-32
Ribeiro P, Morley KD, Shapiro LM, Garnett RA, Hughes GR, Goodwin JF. Left ventricular function in patients with ankylosing spondylitis and Reiter's disease. Eur Heart J 1984;5:419-22
Jiménez-Balderas FJ, García-Rubi D, Pérez-Hinojosa S, Arellano J, Yáñez P, Sanchez ML, et al. Two-dimensional echo Doppler findings in juvenile and adult onset ankylosing spondylitis with long-term disease. Angiology 2001;52:543-8
Piepoli MF, Conraads V, Corrà U, Dickstein K, Francis DP, Jaarsma T, et al. Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail 2011;13:347-57
Azevedo VF, Pecoits-Filho R. Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis. Rheumatol Int 2010;30:1411-6
Papagoras C, Markatseli TE, Saougou I, Alamanos Y, Zikou AK, Voulgari PV, et al. Cardiovascular risk profile in patients with spondyloarthritis. Joint Bone Spine 2014;81:57-63
Ozkan Y. Cardiac Involvement in Ankylosing Spondylitis. J Clin Med Res 2016;8:427-30
Yildirir A, Aksoyek S, Calguneri M, Oto A, Kes S. Echocardiographic evidence of cardiac involvement in ankylosing spondylitis. Clin Rheumatol 2002;21:129-34